DR. NATHAN CHRISTOPHER STEINLE M.D. NPI 1942455423

NPI Details

DR. Nathan Christopher Steinle, M.D. is a retina specialist ophthalmology in Santa Barbara, CA with 21 years of experience. The provider is an ophthalmologist who specializes in the diagnosis and treatment of vitreoretinal diseases. DR. Nathan Christopher Steinle, M.D. NPI is 1942455423. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

525 E MICHELTORENA ST STE A
SANTA BARBARA, CA
ZIP 93103-211
Phone: (805) 963-1648
Fax: (805) 965-5214

The NPI 1942455423 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ranibizumab, 0.1 mg (HCPCS:J2778)
• Imaging of retina (HCPCS:92134)
• Injection, faricimab-svoa, 0.1 mg (HCPCS:J2777)
• Established patient complete exam of visual system (HCPCS:92014)
• Injection of drug into eye (HCPCS:67028)
• Injection, aflibercept, 1 mg (HCPCS:J0178)
• Extended exam of the back part of the eye with optic nerve drawing (HCPCS:92202)
• Extended exam of the back part of the eye with retinal drawing (HCPCS:92201)
• Established patient problem focused exam of visual system (HCPCS:92012)
• Unclassified drugs (HCPCS:J3490)
• Injection, dexamethasone, intravitreal implant, 0.1 mg (HCPCS:J7312)
• Compounded drug, not otherwise classified (HCPCS:J7999)
• Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg (HCPCS:Q5124)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Photography of the retina (HCPCS:92250)
• Exam of retinal blood vessels using a special camera after injection of a dye (HCPCS:92235)
• New patient complete exam of visual system (HCPCS:92004)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Unclassified biologics (HCPCS:J3590)
• Imaging of front third of eye using a special camera after injection of a dye (HCPCS:92287)
• 2d ultrasound scan of eye tissue and structures (HCPCS:76512)
• Injection of drug or substance into membrane covering eyeball (HCPCS:67515)
• Removal of recurring cataract in lens capsule using a laser (HCPCS:66821)
• Destruction of eye fluid (vitreous) between lens and retina using a laser (HCPCS:67039)
• Removal of membrane of retina with removal of internal limiting membrane of retina (HCPCS:67042)
• Removal of recurring cataract in lens capsule by stab incision (HCPCS:66820)
• Repair of detached retina using a laser (HCPCS:67105)
• Injection, bevacizumab, 10 mg (HCPCS:J9035)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Destruction of leaking blood vessels of retina using laser (HCPCS:67228)
• Repair of detached retina with drainage and removal of eye fluid between lens and retina (HCPCS:67108)
• Removal of eye fluid (vitreous) between lens and retina (HCPCS:67036)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Destruction of eye fluid (vitreous) between lens and retina and all of retina using a laser (HCPCS:67040)
• Cataract surgery (HCPCS:NAN11)

The enumeration date for this NPI number is 11/25/2008 and was last updated on 6/6/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.